PF-04937319
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for PF-04937319, covering 2011-11-16 to 2017-03-10. Get the full timeline:
Most recent: Clinical Trial Update: A Trial To Assess The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of Single Doses Of PF-04937319 In Subjects With Type 2 Diabetes Mellitus [Phase 1]